News Sentiment

GOVX sentiment intelligence

GeoVax Labs Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.97 Week of 17 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-17.4% over one week, -27.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -17.4% Price reacting lower
Trend fit Trend inactive -27.3% over four weeks
Fair value -98.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 45
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
Stock Titan 15
TradingKey 6
NewMediaWire 5
TradingView 5
Moomoo 3
simplywall.st 2
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 42
Earnings 13
Deals and strategy 2
Analyst action 2
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 61
The Globe and Mail Direct company coverage

GeoVax Labs Faces Nasdaq Noncompliance and Listing Risk

GeoVax Labs has received a notice from Nasdaq regarding noncompliance with its minimum stockholders' equity requirement, potentially leading to delisting. The company has 45 days to submit a compliance plan. This situation highlights GeoVax's financial strain and introduces uncer

Tone
Negative 19/100
Event
Market update
Published
12 Jul 2026 17:09
Source
The Globe and Mail
Moomoo Direct company coverage

GeoVax Labs | 8-K: Current report

This document is an 8-K current report filed by GeoVax Labs with the SEC. It indicates that the full text of the report is available via a direct link to the SEC filing, and users may need to accept cookies to view it.

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 17:11
Source
Moomoo
TradingView Direct company coverage

GeoVax Labs Received Notice of Noncompliance

GeoVax Labs (GOVX) received a notice from Nasdaq on July 7, 2026, indicating noncompliance with the minimum stockholders' equity requirement of $2,500,000. The company has 45 days, until August 21, 2026, to submit a compliance plan. Trading of GOVX shares continues on Nasdaq.

Tone
Negative 30/100
Event
Market update
Published
10 Jul 2026 20:41
Source
TradingView
Stock Titan Direct company coverage

GeoVax Labs (NASDAQ: GOVX) flagged for Nasdaq $2.5M equity shortfall, delisting risk

GeoVax Labs (NASDAQ: GOVX) received a notice from Nasdaq on July 7, 2026, indicating non-compliance with the $2.5 million minimum stockholders’ equity requirement and alternative standards. The company has 45 calendar days, until August 21, 2026, to submit a compliance plan, with

Tone
Negative 9/100
Event
Market update
Published
10 Jul 2026 19:41
Source
Stock Titan
Moomoo Direct company coverage

GeoVax Labs (GOVX) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for GeoVax Labs (GOVX). It includes information on the general consensus among analysts, price targets, and potential future performance of the company's stock.

Tone
Neutral 50/100
Event
Guidance
Published
09 Jul 2026 03:41
Source
Moomoo
Market source Direct company coverage

GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness

GeoVax Labs, Inc. commented on the U.S. government's recent procurement of additional ACAM2000(R) smallpox vaccine, interpreting it as ongoing strategic validation of long-term vaccine readiness and investment in orthopoxvirus preparedness. The company views this continued federa

Tone
Positive 74/100
Event
Market update
Published
02 Jul 2026 01:12
Source
Market source
TradingView Direct company coverage

Price to earnings forward of GeoVax Labs, Inc. – NASDAQ:GOVX

This page from TradingView provides financial information for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its price-to-earnings forward metric. The content appears to be a financial data presentation rather than an analytical article, showing market data and naviga

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 18:08
Source
TradingView
TradingView Direct company coverage

GeoVax Labs, Inc. Actuals & Estimates (NASDAQ:GOVX)

This article provides an overview of GeoVax Labs, Inc. (NASDAQ: GOVX) stock, including its current price, market capitalization, and historical performance. It also details analyst forecasts, past earnings, and upcoming financial reporting dates for the biotechnology company. The

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 10:39
Source
TradingView
TradingView Direct company coverage

Price to sales forward of GeoVax Labs, Inc. – NASDAQ:GOVX

This article provides financial data for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its forward price-to-sales ratio. It indicates that the company's financial information, including period value, change, and percentage change, is available, likely through the Tra

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 03:42
Source
TradingView
Stock Titan Direct company coverage

[Form 4] GeoVax Labs, Inc. Insider Trading Activity

GeoVax Labs, Inc. reported insider trading activity where Chief Medical Officer Kelly T. McKee Jr. received a grant of 17,600 stock options, exercisable at $1.18 per share. These options vest in three equal annual installments and expire on June 17, 2036. Following this transacti

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 12:40
Source
Stock Titan
Investing.com South Africa Direct company coverage

Form 4 GeoVax Labs Inc For: 22 June By Investing.com

This article from Investing.com simply announces a Form 4 filing for GeoVax Labs Inc. on June 22nd. It does not provide any further details about the content of the filing or its implications. The article primarily consists of navigational elements and market data, typical of a f

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 10:10
Source
Investing.com South Africa
Stock Titan Direct company coverage

Director at GeoVax (GOVX) receives 6,000-share stock option grant

GeoVax Labs, Inc. director Randal D. Chase was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and will expire on June 17, 2036. This transaction is a grant and not an open-market purchase or sale of existi

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 10:10
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax Labs (GOVX) CFO awarded 17,600 stock options in new grant

GeoVax Labs' CFO, Mark Reynolds, was granted 17,600 stock options with an exercise price of $1.18 per share. These options, expiring on June 17, 2036, will become exercisable in three equal annual installments on the first three anniversaries of the grant date, as reported in a F

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 09:39
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax (GOVX) director awarded 6,000 stock options at $1.18 strike

GeoVax Labs, Inc. director Robert T. McNally was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction was a compensation-related award and not an op

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 09:39
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax (GOVX) director awarded 6,000 stock options at $1.18 exercise price

GeoVax Labs, Inc. director Morgan Jayne was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and are set to expire on June 17, 2036. This transaction is categorized as a compensation-related award of derivat

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 22:10
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax (GOVX) director receives 6,000 stock options at $1.18 strike

GeoVax Labs, Inc. director John N. Spencer Jr has been granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction is categorized as an acquisition of deri

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 22:10
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax Labs (GOVX) director gets grant of 6,000 stock options

GeoVax Labs director Dean G. Kollintzas was granted 6,000 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and expire on June 17, 2036. This transaction is categorized as a compensation-related award, not a market purchase, increasing his de

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:40
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax (GOVX) CEO David Dodd granted 29,300 stock options at $1.18 strike

GeoVax Labs, Inc. President and CEO David A. Dodd was granted 29,300 stock options with an exercise price of $1.18 per share. These options, which expire on June 17, 2036, will vest in three equal annual installments on the first three anniversaries of the grant date. This transa

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

GeoVax Labs (GOVX) VP receives grant of 17,600 stock options

GeoVax Labs, Inc. (GOVX) VP of Business Development, John W. Sharkey, received a grant of 17,600 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and will vest in three equal annual installments, expiring on June 17, 2036. This transaction i

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Director at GeoVax Labs (NASDAQ: GOVX) granted 6,000 options

GeoVax Labs director Nicole Lemerond was granted 6,000 stock options, which allow her to purchase common stock at an exercise price of $1.18 per share, with an expiration date of June 17, 2036. This transaction is classified as a routine equity compensation award, not an open-mar

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
TradingKey Direct company coverage

GeoVax Labs Inc (GOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for GeoVax Labs Inc (GOVX) by business segments and regions. However, it explicitly states that the relevant financial data has not yet been disclosed by the company, making a detailed analysis impossible at thi

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 19:39
Source
TradingKey
TradingKey Direct company coverage

GeoVax Labs Inc (GOVX) Institutional Confidence

This article provides an overview of institutional confidence in GeoVax Labs Inc (GOVX), highlighting key shareholders and their holdings. The company's stock information, including its recent price and market capitalization, is also presented, alongside a breakdown of various fi

Tone
Positive 77/100
Event
Market update
Published
18 Jun 2026 19:39
Source
TradingKey
TradingKey Direct company coverage

GeoVax Labs Inc (GOVX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an overview of GeoVax Labs Inc.'s (GOVX) shareholder structure, detailing major institutional shareholders and their holdings. It lists top shareholders like Citadel Advisors LLC and Renaissance Technologies LLC, along with various shareholder types and thei

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 03:09
Source
TradingKey
TradingKey Direct company coverage

GeoVax Labs Inc (GOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of GeoVax Labs Inc (GOVX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and lists several stock merger events from January 2024 and one scheduled for January 2026. The data

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 02:09
Source
TradingKey